24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
22.46% |
|
ENZYME DYNAMICS |
21.93% |
|
CANCER |
19.25% |
|
ALZHEIMERS |
17.65% |
|
EBOLA |
9.63% |
|
PLANT LIPID MUTANT SCREENING |
4.81% |
|
GRASPETIDE RING FORMATION |
4.28% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
50.38% |
|
ENZYME DYNAMICS |
16.16% |
|
PEPTIDOMIMETIC CD40L BINDING |
13.4% |
|
CANCER |
9.51% |
|
EBOLA |
6.84% |
|
GRASPETIDE RING FORMATION |
1.62% |
|
PLANT LIPID MUTANT SCREENING |
1.62% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
.48% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
65.08% |
|
ENZYME DYNAMICS |
13.55% |
|
PEPTIDOMIMETIC CD40L BINDING |
7.85% |
|
CANCER |
5.48% |
|
EBOLA |
2.39% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
2.23% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
1.59% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
.56% |
|
GRASPETIDE RING FORMATION |
.46% |
|
PLANT LIPID MUTANT SCREENING |
.46% |
|
ATWRI1 MUTANT SCREENING |
.35% |